RENAL HYPERTENSIVE ANGIOPATHY - COMPARISON BETWEEN CHRONIC NO SUPPRESSION AND DOCA-SALT INTOXICATION

被引:0
|
作者
XU, YC
ARNAL, JF
HINGLAIS, N
APPAY, MD
LABOULANDINE, I
BARIETY, J
MICHEL, JB
机构
关键词
N-G-NITRO-L-ARGININE METHYL ESTER (L-NAME); PLASMA RENIN ACTIVITY; GLOMERULOSCLEROSIS; CYCLIC GMP; RENIN IMMUNOSTAINING;
D O I
暂无
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
N-G-nitro-L-arginine methyl ester (L-NAME) and 11l-desoxycorticosterone plus salt intake (DOCA-salt) hypertensive rat models were compared to study the possible involvement of model-specific factors in the development of renal angiopathy and left ventricular hypertrophy (LVH). Blood pressure was measured in L-NAME, DOCA-salt hypertensive, and control Wistar rats, and the lesions of nephroangiosclerosis and left ventricular hypertrophy were evaluated after 7 weeks. Arterial wall cyclic guanosine monophosphate, plasma renin activity (PRA), and renal renin storage were assessed in parallel. For the same level of hypertension in the two models, the renal arterial fibrinoid necrotic lesions were significantly more frequent in L-NAME than in DOCA salt hypertensive rats. In DOCA-salt hypertensive rats, PRA was decreased and arterial cGMP increased compared to controls. In the L-NAME model, arterial cGMP decreased and PRA showed a bimodal distribution in this intermediate stage of hypertensive disease. LVH was observed in DOCA-salt rats and only in the L-NAME rats with a high level of PRA. There was a close correlation between the lesions of nephroangiosclerosis, left ventricular index, and plasma renin activity in L-NAME rats. We therefore suggest that the activation of the renin-angiotensin system participates specifically in the development of the second stage of hypertension during chronic blockade of NO synthase involving nephroangiosclerosis and LVH.
引用
收藏
页码:167 / 176
页数:10
相关论文
共 50 条
  • [1] IMPORTANCE OF RENAL NERVES IN THE RENAL RESPONSES TO ANP IN DOCA-SALT HYPERTENSIVE RATS
    ZEIGLER, DW
    PATEL, KP
    FASEB JOURNAL, 1991, 5 (06): : A1483 - A1483
  • [2] Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats
    Wang, Dong
    Luo, Yuhuan
    Myakala, Komuraiah
    Orlicky, David J.
    Dobrinskikh, Evgenia
    Wang, Xiaoxin
    Levi, Moshe
    SCIENTIFIC REPORTS, 2017, 7
  • [3] Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats
    Eun Hui Bae
    In Jin Kim
    Seong Kwon Ma
    Soo Wan Kim
    Hypertension Research, 2010, 33 : 255 - 262
  • [4] INFLUENCE OF EICOSANOIDS ON RENAL-FUNCTION OF DOCA-SALT HYPERTENSIVE RATS
    ROMAN, RJ
    KALDUNSKI, ML
    MATTSON, DL
    MISTRY, M
    NASJLETTI, A
    HYPERTENSION, 1988, 12 (03) : 287 - 294
  • [5] Rosiglitazone prevents the progression of renal injury in DOCA-salt hypertensive rats
    Bae, Eun Hui
    Kim, In Jin
    Ma, Seong Kwon
    Kim, Soo Wan
    HYPERTENSION RESEARCH, 2010, 33 (03) : 255 - 262
  • [6] CHANGES IN RENAL BETA-ADRENOCEPTORS IN DOCA-SALT HYPERTENSIVE RATS
    FUKUDA, K
    KUCHII, M
    HANO, T
    OHTANI, H
    UESHIMA, K
    NISHIO, I
    MASUYAMA, Y
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1982, 46 (08): : 849 - 849
  • [7] Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats
    Dong Wang
    Yuhuan Luo
    Komuraiah Myakala
    David J. Orlicky
    Evgenia Dobrinskikh
    Xiaoxin Wang
    Moshe Levi
    Scientific Reports, 7
  • [8] ANTIHYPERTENSIVE AND RENAL VASODILATOR EFFECT OF DILTIAZEM IN DOCA-SALT HYPERTENSIVE DOG
    ZIMMERMAN, BG
    GOERING, JL
    RAICH, PC
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (06) : 730 - 735
  • [9] Renal medullary NADPH oxidase activity in DOCA-salt hypertensive rats
    Banning, Joseph E.
    Schneider, Markus P.
    Morgan, Noah C.
    Sullivan, Jennifer C.
    Pollock, Jennifer S.
    Pollock, David M.
    FASEB JOURNAL, 2007, 21 (06): : A1364 - A1364
  • [10] SUPPRESSION OF RENAL SYMPATHETIC ACTIVITY WITH POTASSIUM SUPPLEMENT IN DOCA-SALT RATS
    SATO, Y
    FUJITA, T
    JAPANESE HEART JOURNAL, 1984, 25 (02): : 253 - 261